Literature DB >> 29076156

Association between serious psychological distress and nonparticipation in cancer screening and the modifying effect of socioeconomic status: Analysis of anonymized data from a national cross-sectional survey in Japan.

Masaki Fujiwara1, Masatoshi Inagaki2, Naoki Nakaya3, Maiko Fujimori4, Yuji Higuchi5, Kyoko Kakeda6, Yosuke Uchitomi7, Norihito Yamada1.   

Abstract

BACKGROUND: It is unclear whether individuals who have serious psychological distress (SPD) are less likely to participate in screening tests for gastric cancer, lung cancer, and other types of cancer. Of the few studies that have examined the association between SPD and participation in cancer screening, none have reported modifying effects of educational, marital, or employment status.
METHODS: The authors analyzed a national representative data set from the 2010 Comprehensive Survey of Living Conditions of Japan., including individuals aged <69 years who met the national program criteria for each type of cancer screening (colorectal, gastric, and lung cancers, n = 29,926; breast cancer, n = 15,423; and cervical cancer, n = 24,735). SPD was defined as a score of 13 or greater on the Kessler 6 scale. Logistic regression analyses were conducted to examine the association between SPD and participation in cancer screening, and multivariate analyses stratified by socioeconomic status also were conducted.
RESULTS: SPD was significantly associated with a lower odds ratio (OR) for participation in screening for colorectal cancer (OR, 0.743; 95% confidence interval [CI], 0.638-0.866), gastric cancer (OR, 0.823; 95% CI, 0.717-0.946), and lung cancer (OR, 0.691; 95% CI, 0.592-0.807). Only educational status significantly modified the effect of SPD on participation in these 3 types of cancer screening (P < .05).
CONCLUSIONS: Individuals with SPD, especially those with lower education levels, were less likely to participate in screening for colorectal, gastric, and lung cancers. Individuals with SPD should be encouraged and supported to participate in cancer screening tests. Cancer 2018;124:555-62.
© 2017 American Cancer Society. © 2017 American Cancer Society.

Entities:  

Keywords:  cancer screening; early detection of cancer; health care disparities; mental disorder; psychological distress

Mesh:

Year:  2017        PMID: 29076156     DOI: 10.1002/cncr.31086

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  Pre-diagnosis major life stressors and breast cancer outcomes.

Authors:  Tanmayi Pai; Lauren Cornell; Danushka Seneviratne; Shehzad Niazi; Dawn Mussallem; Laura Vallow
Journal:  Breast Cancer Res Treat       Date:  2021-04-12       Impact factor: 4.872

2.  The Psychological Impact of Referral for Mammography Screening for Breast Cancer Among Women in Muscat Governorate: A cross-sectional study.

Authors:  Nouf M Al-Alawi; Nabila Al-Balushi; Asma A Al Salmani
Journal:  Sultan Qaboos Univ Med J       Date:  2019-11-05

3.  Financial Literacy, Financial Education, and Cancer Screening Behavior: Evidence from Japan.

Authors:  Trinh Xuan Thi Nguyen; Sumeet Lal; Sulemana Abdul-Salam; Mostafa Saidur Rahim Khan; Yoshihiko Kadoya
Journal:  Int J Environ Res Public Health       Date:  2022-04-07       Impact factor: 4.614

4.  Cancer cases detected in the prevention and control service of a private cancer clinic in Peru.

Authors:  José Revilla-López; Andrea Anampa-Guzmán; Luis Casanova Marquez; Katrina Weeks; Suzanne Pollard; Adriel Olórtegui-Yzú; María Ruiz-Velazco; Alba Davila-Edquen; Daniel Castro-Dorer; Juan Wong-Barrenechea; Jossira Abad-Seminario; Pamela Gonzáles-Ramos; Fiorella Rivera-Sandoval; Carlos Carracedo-Gonzáles
Journal:  Infect Agent Cancer       Date:  2019-11-29       Impact factor: 2.965

5.  Association between socioeconomic factors at diagnosis and survival in breast cancer: A population-based study.

Authors:  Peng Ji; Yue Gong; Chang-Chuan Jiang; Xin Hu; Gen-Hong Di; Zhi-Ming Shao
Journal:  Cancer Med       Date:  2020-01-20       Impact factor: 4.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.